According to Gold Finance, Nasdaq-listed company Predictive Oncology announced plans to raise approximately $344 million through two private placements of publicly traded equity to support the launch of the Aethir (ATH) treasury. It is reported that DNA Holdings Venture, Inc. will serve as the strategic advisor for the digital money treasury and the financial advisor for the company's digital assets.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Predictive Oncology plans to raise approximately $344 million to support the launch of Aethir (ATH) treasury.
According to Gold Finance, Nasdaq-listed company Predictive Oncology announced plans to raise approximately $344 million through two private placements of publicly traded equity to support the launch of the Aethir (ATH) treasury. It is reported that DNA Holdings Venture, Inc. will serve as the strategic advisor for the digital money treasury and the financial advisor for the company's digital assets.